Monday, Dec 18, 2017
engineered enzymes for better healthcare

Irish company Enzolve have developed a new, cheaper method of screening newborns for PKU. They hope to increase the percentage of newborns screened for PKU as currently only between 30-35% of babies are effectively screened...

Read full article on the web PKU Exchange May 2009 or in pdf format   pdf_button

Back to the News page

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...